Last update 09 Nov 2024

ARI-0003

Overview

Basic Info

Drug Type
CAR-T
Synonyms-
Target
CD19
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
B-Cell LymphomaNon-Hodgkin's lymphoma refractoryRecurrent Non-Hodgkin Lymphoma+ [1]
Inactive Indication-
Originator Organization
Institut d'Investigacions Biomèdiques August Pi I SunyerInstitut d'Investigacions Biomèdiques August Pi I Sunyer
Active Organization
Fundació Clinic per a la Recerca BiomedicaInstitut d'Investigacions Biomèdiques August Pi I SunyerInstitut d'Investigacions Biomèdiques August Pi I Sunyer
Inactive Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with ARI-0003
CTIS2023-507213-97-00 / RecruitingIIT
First in human study of the infusion of ARI0003 cells in relapsed/refractory to treatment B-cell aggressive lymphoma
NCT06097455 / Not yet recruitingEarly Phase 1IIT
First in Human, Pilot, Open-label, Prospective, Multicentre, Non-randomised Clinical Trial to Evaluate the Safety and Efficacy of ARI0003 (CART CD19/ CD269 Cells) in Patients With Relapsed/Refractory B-cell Aggressive Lymphoma
100 Clinical Results associated with ARI-0003
Login to view more data
100 Translational Medicine associated with ARI-0003
Login to view more data
100 Patents (Medical) associated with ARI-0003
Login to view more data
100 Deals associated with ARI-0003
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
B-Cell LymphomaPhase 1
ES
Fundació Clinic per a la Recerca Biomedica
15 Jan 2024
Non-Hodgkin's lymphoma refractoryPhase 1
ES
Fundació Clinic per a la Recerca Biomedica
15 Jan 2024
Recurrent Non-Hodgkin LymphomaPhase 1
ES
Fundació Clinic per a la Recerca Biomedica
15 Jan 2024
Non-Hodgkin LymphomaPreclinical-
Institut d'Investigacions Biomèdiques August Pi I SunyerInstitut d'Investigacions Biomèdiques August Pi I Sunyer
05 Nov 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free